753 related articles for article (PubMed ID: 30347211)
1. The neuropsychopharmacology of cannabis: A review of human imaging studies.
Bloomfield MAP; Hindocha C; Green SF; Wall MB; Lees R; Petrilli K; Costello H; Ogunbiyi MO; Bossong MG; Freeman TP
Pharmacol Ther; 2019 Mar; 195():132-161. PubMed ID: 30347211
[TBL] [Abstract][Full Text] [Related]
2. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
Weinstein A; Livny A; Weizman A
Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
4. Pregnenolone can protect the brain from cannabis intoxication.
Vallée M; Vitiello S; Bellocchio L; Hébert-Chatelain E; Monlezun S; Martin-Garcia E; Kasanetz F; Baillie GL; Panin F; Cathala A; Roullot-Lacarrière V; Fabre S; Hurst DP; Lynch DL; Shore DM; Deroche-Gamonet V; Spampinato U; Revest JM; Maldonado R; Reggio PH; Ross RA; Marsicano G; Piazza PV
Science; 2014 Jan; 343(6166):94-8. PubMed ID: 24385629
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
7. Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation.
Whitfield-Gabrieli S; Fischer AS; Henricks AM; Khokhar JY; Roth RM; Brunette MF; Green AI
Schizophr Res; 2018 Apr; 194():70-77. PubMed ID: 28823723
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.
Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081
[TBL] [Abstract][Full Text] [Related]
9. The effects of cannabis use on salience attribution: a systematic review.
Wijayendran SB; O'Neill A; Bhattacharyya S
Acta Neuropsychiatr; 2018 Feb; 30(1):43-57. PubMed ID: 27866486
[TBL] [Abstract][Full Text] [Related]
10. [Does cannabis use lead to schizophrenia?].
Heekeren K
Praxis (Bern 1994); 2011 Nov; 100(22):1361-7. PubMed ID: 22048912
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide DNA Methylation Profiling Reveals Epigenetic Changes in the Rat Nucleus Accumbens Associated With Cross-Generational Effects of Adolescent THC Exposure.
Watson CT; Szutorisz H; Garg P; Martin Q; Landry JA; Sharp AJ; Hurd YL
Neuropsychopharmacology; 2015 Dec; 40(13):2993-3005. PubMed ID: 26044905
[TBL] [Abstract][Full Text] [Related]
12. Different Effects of Cannabis Abuse on Adolescent and Adult Brain.
Dhein S
Pharmacology; 2020; 105(11-12):609-617. PubMed ID: 32629444
[TBL] [Abstract][Full Text] [Related]
13. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
Niesink RJ; Rigter S; Koeter MW; Brunt TM
Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
[TBL] [Abstract][Full Text] [Related]
14. What Can Rats Tell Us about Adolescent Cannabis Exposure? Insights from Preclinical Research.
Renard J; Rushlow WJ; Laviolette SR
Can J Psychiatry; 2016 Jun; 61(6):328-34. PubMed ID: 27254841
[TBL] [Abstract][Full Text] [Related]
15. Clinical Approach to the Heavy Cannabis User in the Age of Medical Marijuana.
Cermak TL
J Psychoactive Drugs; 2016; 48(1):31-40. PubMed ID: 26881331
[TBL] [Abstract][Full Text] [Related]
16. Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.
Batalla A; Crippa JA; Busatto GF; Guimaraes FS; Zuardi AW; Valverde O; Atakan Z; McGuire PK; Bhattacharyya S; Martín-Santos R
Curr Pharm Des; 2014; 20(13):2168-85. PubMed ID: 23829359
[TBL] [Abstract][Full Text] [Related]
17. Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence.
Colizzi M; McGuire P; Pertwee RG; Bhattacharyya S
Neurosci Biobehav Rev; 2016 May; 64():359-81. PubMed ID: 26987641
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of Medical Cannabis.
Amin MR; Ali DW
Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
[TBL] [Abstract][Full Text] [Related]
20. Marijuana poisoning.
Fitzgerald KT; Bronstein AC; Newquist KL
Top Companion Anim Med; 2013 Feb; 28(1):8-12. PubMed ID: 23796481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
